Protection of bile ducts in liver transplantation: Looking beyond ischemia

Transplantation

Volumn 92, Issue 4, 2011, Pages 373-379

  Op Den Dries, Sanna ^a   Sutton, Michael E ^a   Lisman, Ton ^a   Porte, Robert J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Bile ducts; Cholangiopathy; Complications; Injury; Liver Transplantation

Indexed keywords

BILE SALT;

BILE DUCT OBSTRUCTION; CHOLANGIOGRAPHY; COLD ISCHEMIA; DISEASE SEVERITY; DONOR; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; HYDROPHOBICITY; IMMUNE MEDIATED INJURY; ISCHEMIC PRECONDITIONING; LIVER FAILURE; LIVER GRAFT; LIVER ISCHEMIA; LIVER TRANSPLANTATION; MORBIDITY; NONANASTOMOTIC BILIARY STRICTURE; ORTHOTOPIC TRANSPLANTATION; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; RISK FACTOR; ROUX Y ANASTOMOSIS;

ANASTOMOTIC LEAK; BILE ACIDS AND SALTS; BILE DUCT DISEASES; BILE DUCTS; CONSTRICTION, PATHOLOGIC; HUMANS; ISCHEMIA; LIVER TRANSPLANTATION; REPERFUSION INJURY; RISK FACTORS;

EID: 80051793095     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318223a384     Document Type: Review

References (57)

1. Buck DG, Zajko AB. Biliary complications after orthotopic liver transplantation. Tech Vasc Interv Radiol 2008;11:51.
2. Verdonk RC, Buis CI, Porte RJ, et al. Biliary complications after liver transplantation: A review. Scand J Gastroenterol Suppl 2006;243:89.
3. Wojcicki M, Milkiewicz P, Silva M. Biliary tract complications after liver transplantation: A review. Dig Surg 2008;25:245.
4. Morelli J, Mulcahy HE, Willner IR, et al. Endoscopic treatmentof postliver transplantation biliary leaks with stent placement across the leak site. Gastrointest Endosc 2001;54:471.
5. Osorio RW, Freise CE, Stock PG, et al. Nonoperative management of biliary leaks after orthotopic liver transplantation. Transplantation 1993;55:1074.
6. Righi D, Franchello A, Ricchiuti A, et al. Safety and efficacy of the percutaneous treatment of bile leaks in hepaticojejunostomy or splitliver transplantation without dilatation of the biliary tree. Liver Transpl 2008;14:611.
7. Shuhart MC, Kowdley KV, McVicar JP, et al. Predictors of bile leaks after T-tube removal in orthotopic liver transplant recipients. Liver Transpl Surg 1998;4:62.
8. Jagannath S, Kalloo AN. Biliary complications after liver transplantation. Curr Treat Options Gastroenterol 2002;5:101.
9. Sharma S, Gurakar A, Jabbour N. Biliary strictures following liver transplantation: Past, present and preventive strategies. Liver Transpl 2008;14:759.
10. Verdonk RC, Buis CI, Porte RJ, et al. Anastomotic biliary strictures after liver transplantation: Causes and consequences. Liver Transpl 2006;12:726.
11. Zoepf T, Maldonado-Lopez EJ, Hilgard P, et al. Balloon dilatation vs. balloon dilatation plus bile duct endoprostheses for treatment of anastomotic biliary strictures after liver transplantation. Liver Transpl 2006;12:88.
12. Buis CI, Hoekstra H, Verdonk RC, et al. Causes and consequences of ischemic-type biliary lesions after liver transplantation. J Hepatobiliary Pancreat Surg 2006;13:517.
13. Sanchez-Urdazpal L, Gores GJ, Ward EM, et al. Ischemic-type biliary complications after orthotopic liver transplantation. Hepatology 1992;16:49.
14. Graziadei IW, Schwaighofer H, Koch R, et al. Long-term outcome of endoscopic treatment of biliary strictures after liver transplantation. Liver Transpl 2006;12:718.
15. Buis CI, Verdonk RC, van der Jagt EJ, et al. Nonanastomotic biliary strictures after liver transplantation, part 1: Radiological features and risk factors for early vs. late presentation. Liver Transpl 2007;13:708.
16. Stange BJ, Glanemann M, Nuessler NC, et al. Hepatic artery thrombosis after adult liver transplantation. Liver Transpl 2003;9:612.
17. Noack K, Bronk SF, Kato A, et al. The greater vulnerability of bile duct cells to reoxygenation injury than to anoxia. Implications for the pathogenesis of biliary strictures after liver transplantation. Transplantation 1993;56:495.
18. Montalvo-Jave EE, Pina E, Montalvo-Arenas C, et al. Role of ischemic preconditioning in liver surgery and hepatic transplantation. J Gastrointest Surg 2009;13:2074.
19. Gurusamy KS, Kumar Y, Sharma D, et al. Ischaemic preconditioning for liver transplantation. Cochrane Database Syst Rev 2008; CD006315.
20. Dubbeld J, Hoekstra H, Farid W, et al. Similar liver transplantation survival with selected cardiac death donors and brain death donors. Br J Surg 2010;97:744.
21. Saidi RF, Bradley J, Greer D, et al. Changing pattern of organ donation at a single center: Are potential brain dead donors being lost to donation after cardiac death? Am J Transplant 2010;10:2536.
22. Abt P, Crawford M, Desai N, et al. Liver transplantation from controlled non-heart-beating donors: An increased incidence of biliary complications. Transplantation 2003;75:1659.
23. Garcia-Valdecasas JC, Tabet J, Valero R, et al. Evaluation of ischemic injury during liver procurement from non-heart-beating donors. Eur Surg Res 1999;31:447.
24. Chan EY, Olson LC, Kisthard JA, et al. Ischemic cholangiopathy following liver transplantation from donation after cardiac death donors. Liver Transpl 2008;14:604.
25. Grewal HP, Willingham DL, Nguyen J, et al. Liver transplantation using controlled donation after cardiac death donors: An analysis of a large single-center experience. Liver Transpl 2009;15:1028.
26. Pine JK, Aldouri A, Young AL, et al. Liver transplantation following donation after cardiac death: An analysis using matched pairs. Liver Transpl 2009;15:1072.
27. Pirenne J, Van GF, Coosemans W, et al. Type of donor aortic preservation solution and not cold ischemia time is a major determinant of biliary strictures after liver transplantation. Liver Transpl 2001;7:540.
28. Moench C, Moench K, Lohse AW, et al. Prevention of ischemic-type biliary lesions by arterial back-table pressure perfusion. Liver Transpl 2003;9:285.
29. Stewart ZA, Cameron AM, Singer AL, et al. Histidine-Tryptophan- Ketoglutarate (HTK) is associated with reduced graft survival in deceased donor livers, especially those donated after cardiac death. Am J Transplant 2009;9:286.
30. Yamauchi JI, Richter S, Vollmar B, et al. Warm preflush with streptokinase improves microvascular procurement and tissue integrity in liver graft retrieval from non-heart-beating donors. Transplantation 2000;69:1780.
31. Porte RJ, Clavien PA. Preflush with plasminogen activator in nonheart-beating donors: Is it worth it? Transplantation 2000;69:1769.
32. de RO, Lehmann K, Clavien PA. Preconditioning, organ preservation, and postconditioning to prevent ischemia-reperfusion injury to the liver. Liver Transpl 2009;15:1172.
33. Rapaport FT, Dausset J. Activity of the ABO antigen system as a determinant of histocompatibility in human transplantation. Transplant Proc 1987;19:4487.
34. Rull R, Garcia Valdecasas JC, Grande L, et al. Intrahepatic biliary lesions after orthotopic liver transplantation. Transpl Int 2001;14:129.
35. Sanchez-Urdazpal L, Gores GJ, Ward EM, et al. Clinical outcome of ischemic-type biliary complications after liver transplantation. Transplant Proc 1993;25:1107.
36. Feller RB, Waugh RC, Selby WS, et al. Biliary strictures after liver transplantation: Clinical picture, correlates and outcomes. J Gastroenterol Hepatol 1996;11:21.
37. Guichelaar MM, Benson JT, Malinchoc M, et al. Risk factors for and clinical course of non-anastomotic biliary strictures after liver transplantation. Am J Transplant 2003;3:885.
38. Hoekstra H, Buis CI, Verdonk RC, et al. Is Roux-en-Y choledochojejunostomyan independent risk factor for nonanastomotic biliary strictures after liver transplantation? Liver Transpl 2009;15:924.
39. Halme L, Hockerstedt K, Lautenschlager I. Cytomegalovirus infection and development of biliary complications after liver transplantation. Transplantation 2003;75:1853.
40. Moench C, Uhrig A, Lohse AW, et al. CC chemokine receptor 5delta32 polymorphism-a risk factor for ischemic-type biliary lesions following orthotopic liver transplantation. Liver Transpl 2004;10:434.
41. Op Den Dries S, Buis CI, Adelmeijer J, et al. The combination of primary sclerosing cholangitis and CCR5-Delta32 in recipients is strongly associated with the development of nonanastomotic biliary strictures after liver transplantation. Liver Int 2010; [Epub ahead of print].
42. Dobaczewski M, Xia Y, Bujak M, et al. CCR5 signaling suppresses inflammation and reduces adverse remodeling of the infarcted heart, mediating recruitment of regulatory T cells. Am J Pathol 2010;176:2177.
43. Nozaki T, Rosenblum JM, Schenk AD, et al. CCR5 is required for regulation of alloreactive T-cell responses to single class II MHC-mismatched murine cardiac grafts. Am J Transplant 2009;9:2251.
44. Wysocki CA, Jiang Q, Panoskaltsis-Mortari A, et al. Critical role for CCR5 in the function of donor CD4+CD25 + regulatory T cells during acute graft-versus-host disease. Blood 2005;106:3300.
45. Hertl M, Harvey PR, Swanson PE, et al. Evidence of preservation injury to bile ducts by bile salts in the pig and its prevention by infusions of hydrophilic bile salts. Hepatology 1995;21:1130.
46. Hoekstra H, Porte RJ, Tian Y, et al. Bile salt toxicity aggravates cold ischemic injury of bile ducts after liver transplantation in Mdr2+/-mice. Hepatology 2006;43:1022.
47. Knoop M, Schnoy N, Keck H, et al. Morphological changes of human common bile ducts after extended cold preservation. Transplantation 1993;56:1572.
48. Hofmann AF. The continuing importance of bile acids in liver and intestinal disease. Arch Intern Med 1999;159:2647.
49. Yska MJ, Buis CI, Monbaliu D, et al. The role of bile salt toxicity in the pathogenesis of bile duct injury after non-heart-beating porcine liver transplantation. Transplantation 2008;85:1625.
50. Chen G, Wang SG, Bie P, et al. Endogenous bile salts are associated with bile duct injury in the rat liver transplantation model. Transplantation 2009;87:330.
51. Buis CI, Geuken E, Visser DS, et al. Altered bile composition after liver transplantation is associated with the development of nonanastomotic biliary strictures. J Hepatol 2009;50:69.
52. Geuken E, Visser D, Kuipers F, et al. Rapid increase of bile salt secretion is associated with bile duct injury after human liver transplantation. J Hepatol 2004;41:1017.
53. Xia XF, Francis H, Glaser S, et al. Bile acid interactions with cholangiocytes. World J Gastroenterol 2006;12:3553.
54. Palmeira CM, Rolo AP. Mitochondrially-mediated toxicity of bile acids. Toxicology 2004;203:1.
55. Cheng L, Zhao L, Li D, et al. Role of cholangiocyte bile acid transporters in large bile duct injury after rat liver transplantation. Transplantation 2010;90:127.
56. Beuers U, Hohenester S, de Buy Wenniger LJ, et al. The biliary HCO (3) (-) umbrella: A unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies. Hepatology 2010;52:1489.
57. Guimbellot JS, Fortenberry JA, Siegal GP, et al. Role of oxygen availability in CFTR expression and function. Am J Respir Cell Mol Biol 2008;39:514.